Physician profile
Bradley Rigby
NPI 1851314462
$4,030.17
in general payments reported to CMS, 2019-2025
13 companies · $337 in 2025
The $337 reported for 2025 was more than what 85% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.54 · 2020: $892 · 2021: $290 · 2022: $1,489 · 2023: $442 · 2024: $546 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $569 · Gift: $537 · Education: $148 · Entertainment: $69.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.33 |
| Gift | $537.17 |
| Education | $148.36 |
| Entertainment | $69.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,223.51 | 2019-2025 | |
| Patterson Companies, INC. | $772.49 | 2022-2025 | |
| Dentsply Sirona INC | $724.94 | 2021-2025 | X-Smart, Cerec |
| Premier Dental Products Company | $372.20 | 2024 | Premierair Barnhart 5/6 |
| Keystone Dental INC. | $218.07 | 2023 | |
| Southern Implants North America INC | $203.34 | 2023-2024 | |
| Biohorizons Implant Systems INC. | $167.66 | 2020 | |
| Ultradent Products INC | $164.97 | 2023-2025 | Opalescence |
| Implant Direct Sybron International LLC | $84.69 | 2020-2022 | |
| Nobel Biocare USA | $58.08 | 2023 | Nobelactive |
| Gc America INC. | $14.71 | 2024 | Equia |
| 3m Company | $13.56 | 2019 | |
| Ivoclar Vivadent, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Rigby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.